期刊文献+

C反应蛋白对多发性骨髓瘤细胞系U266增殖机制的研究 被引量:2

Mechanism of C-Reactive Protein on Proliferation of Multiple Myeloma U266 Cells
在线阅读 下载PDF
导出
摘要 为了观察C反应蛋白(CRP)对人骨髓瘤细胞系U266细胞增殖活性的作用机制,将液氮冻存的U266细胞复苏后,悬浮培养,第3天收集细胞备用,分别以不同浓度CRP(0、5、10、20mg/L)培养24小时,采用血液分析仪检测细胞增殖情况,采用逆转录-聚合酶链反应(RT-PCR)方法检测凋亡相关蛋白survivin和HSP90α的表达。结果发现:CRP处理的细胞组增殖率及survivin、HSP90α的表达量均高于对照组(p<0.05),20mg/LCRP组作用最显著;survivin、HSP90α之间表达具有显著相关性(r=0.737,p<0.0001)。结论:CRP是通过调节凋亡抑制蛋白Survivin及HSP90α的表达发挥促进U266细胞增殖的作用。 This study was purposed to investigate the mechanism of C-reactive protein (CRP) on proliferation of U266 cells. The human multiple meyloma cell line U266 was incubated with human CRP(0,5,10,20 mg/L) for 24 hours, then the proliferation level of U266 cells was detected by using blood analyser. The mRNA expressions of survivin and HSP90α were examined by RT-PCR. The results showed that the proliferation ratio was increased, as compared with the control group(p 〈0.05 ) ; furthermore, the mRNA levels of survivin and HSP90α were up-regulated in proportion to the increased CRP concentrations. There was significant correlation between expression of survivin and HSP90et ( r = 0. 737 ,p 〈 0.0001 ) in incubated cells. It is concluded that CRP can stimulate the proliferation of MM cells directly by up-regulating the expression of survivin and HSP90α in MM cells. CRP can be regarded as a potential target for MM treatment.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第5期1242-1245,共4页 Journal of Experimental Hematology
基金 山西省留学人员科研资助项目 编号20081099
关键词 C反应蛋白 SURVIVIN HSP90Α 骨髓瘤 U266细胞 CRP survivin HSP90α multiple myeloma U266 cell
  • 相关文献

参考文献12

  • 1邱录贵.多发性骨髓瘤的发病与国人特点[J].中国实用内科杂志:临床前沿版,2006,26(6):886-888. 被引量:53
  • 2Bharadwaj D, Stein MP, Volzer M, et al. The major receptor for C-reactive protein on leukocytes is Fc-γ receptor II. J Exp Med, 1999 ; 190:585 - 590.
  • 3王晓冬,张晋琳,万纯黔.多发性骨髓瘤患者C反应蛋白水平与病程及预后的关系[J].四川医学,2000,21(8):718-719. 被引量:5
  • 4Yang J, Wezeman M, Zhang X, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell, 2007;12:252 -265.
  • 5Ambrosini G, Aidda C, Altieri DC. A novel anti-apoptosis gene, survivin expressed in cancer and lymphoma. Nat Med, 1997 ;3:917 -921.
  • 6Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome C-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J, 2000;19:4310 - 4322.
  • 7Nimmanapalli R, O q3ryan E, BhallaI K. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res, 2001 ;61:1799 - 1804.
  • 8Hostein I, Robertson D, Distefano F, et al. Inhibition of signal transduction by the Hop90 inhibitor 17-allylamino-17-demethoxy- geldanamycin results in cytostasis and apoptosis. Cancer Res ,2001 ; 61:4003 - 4009.
  • 9Andrulis M, Chatterjee M, Jain S, et al. Heat shock protein 90 alpha and beta are overexpressed in multiple myeloma cells and critically contribute to survival. Verh Dtsch Ges Pathol, 2007 ;91 : 330 - 337.
  • 10Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene, 2004 ; 23 : 4921 - 4929.

二级参考文献16

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 2张之南.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1997.211-213.
  • 3Klein B, et al. Interleukin-6 in human multiple myeloma. Blood,1995,85(4):863
  • 4Legouffe E,et al. C-reactive protein serum level is a valuable and simple prognostic market in non Hodgkin's lymphoma. Lenk-lymphoma, 1998,31(3~4):351
  • 5AMBROSINI G, ADIDA C, ALTIENI D C. A novel anti-apoptosis gene, survivin expressed in cancer and lymphoma[J]. Nat Med, 1997,3 (8) :917-921.
  • 6KANDA N, SENO H, KONDA Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells [ J ]. Oncogene, 2004,23 ( 28 ) : 4921-4929.
  • 7JOHANNES B, SALNITSKI V P, GUNGA H C, et al. Regulatory change at high altitudes in comparison with post-space-flight reaction[J]. J Gravit Physiol,1999,6( 1 ) :45-46.
  • 8PRATT W B, TOFT D O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery [J]. Exp Biol Med (Maywood) ,2003,228(2) :111-133.
  • 9EVAN G I, VOUSDEN K H. Proliferation, cell cycle and apoptosis in cancer[ J]. Nature,2001,411 (6835) :342-348.
  • 10LSAACS JS,XU W,NECKERS L. Heat shock protein 90 as a molecular target for cancer therapeutics [ J ]. Cancer Cell, 2003,3 (3) :213-217.

共引文献55

同被引文献21

  • 1杨志才,高玉洁,张春明,钱铸山.多发性骨髓瘤血清蛋白电泳与免疫学分型[J].国外医学(临床生物化学与检验学分册),2005,26(7):413-414. 被引量:16
  • 2黄炜,陈新美,张志凌,罗惠玲,张东方.18β-甘草次酸诱导人乳腺癌细胞凋亡及其细胞内Ca^(2+)水平的变化[J].中国癌症杂志,2006,16(2):102-106. 被引量:18
  • 3王银环,范钰,张尤历,张英平.18β-甘草次酸对人胃癌细胞BGC823增殖的抑制[J].江苏大学学报(医学版),2007,17(3):251-253. 被引量:17
  • 4Ambrosini G, Adida C, Altieri DC. A novel anfi-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997;3 (8) :917-921.
  • 5Natarbartolo M, Cervello M, Dusonchet L, et al. Resistance to diverse apoptotic triggers in multidrug resistant HL-60 cells and its possible factors IAP (inhibitory of apoptosis proteins ). Cancer Lett,2002 ; 180( 1 ) :91 - 101.
  • 6Altieri DC. Survivin and lAP proteins in cell-death mechanisms. Biochem J, 2010; 430(2) : 199 -205.
  • 7Guha M, Altieri DC. Survivin as a global taget of intrinsic tumor suppression networks. Cell Cycle,2009;8(17) : 2708 -2713.
  • 8Grube M, Morit S, Oberman EC, et al. CD8+ T cell reactive to survivin antigen in patients with multiple myeloma. Clin Cancer Res ,2007 ; 13 ( 3 ) : 1053 - 1060.
  • 9Kao TC, Shyu MH, Yen GC. Glycyrrhizic acid and 18 beta-glycyrrhetinic acid inhibit inflammation via Pl3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J Agric Food Chem, 2010 ;58 ( 15 ) :8623 - 8629.
  • 10Cinatl J, Morgenstem B, Bauer G, et al. Glycyrrhizih, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 2003;361 (9374) : 2045-2046.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部